Indeed, fingolimod has been shown in preclinical studies to have anticancer activity in various cancer cell types, including bladder cancer (87), breast cancers (8891), glioblastoma (92, 93), hepatocellular carcinoma (9496), malignant mesothelioma (97), leukemia and lymphoma (98104), lung cancer (105107), liver cancer (108), pancreatic cancer (109), bladder cancer (87), renal cancer (110)
Nauk Visn Uzhhorod Univ Ser Khim 1:19 Cock IE et al (2022) The feasibility of southern African traditional plant therapies for ophthalmic use
Flavonoids demonstrate structural and functional effects through enzyme inhibition, acting as antioxidants, damaging cells, triggering host defense mechanisms, and blocking virus cell attachment and penetration 103, 104
doi: 10.1016/S1474-4422(06)70598-1, PMID: [DOI] [PubMed] [Google Scholar] 21